day 1 agenda
| World Congress on Vaccines June 24-25 @ Prague, Czech Republic Scientific Program |
|
| Day -1 | June 24, 2024 | |
| Registrations | 09:00-09:30 | |
| Opening Ceremony & Moderator Speech | 09:30-09:40 | |
| Keynote Presentations | |
| 09:40-10:10 | Title: Characterization of Recombinant Vesicular Stomatitis Virus rVSV-based Bivalent Vaccine Against SARS-CoV-2 and Influenza A Virus |
| Xiaojian Yao, University of Manitoba, Canada | |
| 10:10-10:40 | Title: Diagnostic targets and point-of-care serodiagnostic test for Trichomonas vaginalis, the most prevalent, non-viral sexually transmitted infection |
| Alderete, John F, Washington University, USA | |
| 10:40-11:10 | Title: Cellular topography and virus particle imaging by high-resolution SEM incorporated a freeze-drying and gaseous nitrogen-based approach |
| Kunihiro Uryu, Janelia Reserch Campus, USA | |
| Group Photo & Refreshment Break | 11:10-11:30 | |
| Technical Session: 1 | |
| 11:30-11:50 | Title: Insights into the function of ESCRT complex and LBPA in ASFV infection |
| Miguel Ángel Cuesta-Geijo, INIA CSIC, Spain | |
| 11:50-12:10 | Speaker Slot available |
| 12:10-12:30 | Title: First Identification of Trichinella pseudospiralis in a Golden Jackal (Canis aureus) in Romania |
| Narcisa Mederle, University of Life Sciences, Romania | |
| 12:30-12:50 | Title:A Synthetic Peptide Vaccine Demonstrates Prophylactic and Therapeutic Efficacy Against Streptococcal Superficial and Invasive |
| Manisha Pandey, Griffith University, Australia | |
| 12:50-13:10 | Title: miR-204 suppresses porcine reproductive and respiratory syndrome virus (PRRSV) replication via inhibiting LC3B-mediated autophagy |
| Wen-hai Feng, China Agricultural University, China | |
| Lunch Break | 13:10-14:00 | |
| Technical Session: 2 | |
| 14:00-14:20 | Title: Virus-derived Serpin Targets Systemic Immune and Coagulation Disorders Improving Outcomes and Survival in Murine Models of Inflammatory Disease |
| Alexandra, Arizona State University (ASU), Biodesign Institute, USA | |
| 14:20-14:40 | Title: Alphaherpesvirus UHRF1 deficiency inhibits alphaherpesvirus through inducing RIG-I-IRF3-mediated interferon production |
| Jun Tung, China Agricultural University, China | |
| 14:40-15:00 | Title: C500 variants conveying complete mucosal immunity against fatal infections of pigs with Salmonella enterica serovar Choleraesuis C78-1 or F18+ Shiga toxin-producing Escherichia coli |
| Guoping Liu, Yangtze University, China | |
| 15:00-15:20 | Title: The role of circular RNA in dendritic cells: a new target for robust dendritic cell vaccine |
| Xiufen Zheng,Western University, London, Canada | |
| 15:20-15:40 | Title:TBA |
| Balazs Sarkadi, RCNS Hungary - CelluVir Kft, Hungary | |
| 15:40-16:00 | Title: Barriers to childhood immunization uptake in the countries in West Africa: A Systematic Literature Review |
| Geeta Hitch, University of Sunderland in London, UK | |
| Refreshment Break | 16:00-16:10 | |
| 16:10-16:30 | Title: Identify patterns and risk factors of post-COVID-19 vaccination side effects |
| Wang Wei, Brigham and Women's Hospital / Harvard Medical Schoool, USA | |
| 16:30-16:50 | Title: Navigating the future adult vaccine landscape - innovation, an aging population and crowded schedules |
| Charles Jones, Pfizer, USA | |
| 16:50-17:10 | Title: Longitudinal anti-SARS-CoV-2antibody immune response in acute and convalescent patients |
| Cecilia Ximénez, National University of Mexico, Mexico | |
| 17:10-17:30 | Title: Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines |
| Deok Ryun Kim, International Vaccine Institute, South Korea | |
| Award Ceremony | |
day 2 agenda
| Day -2 | June 25, 2024 | |
| Technical Session: 3 | |
| 09:40-10:10 | Title: The Flexible, Versatile and Fast GreGT Platform of Fully Deleted Helper-Virus Independent Adenoviral Vectors |
| Uwe Staerz, Greffex, INC, USA | |
| 10:10-10:40 | Speaker Slot available |
| 10:40-11:10 | Title: An RNA-based vaccine for tuberculosis |
| Rhea Coler, University of Washington/Seattle Children's Research Institute,USA | |
| 12:00-12:20 | Title: Neutralization of SARS-CoV-2 by single-chain antibodies – a way to vaccine development |
| Horacio Bach, University of British Columbia, Canada | |
| 12:20-12:40 | Speaker Slot available |
| 12:40-13:00 | Speaker Slot available |
| Lunch Break | 13:00-14:00 | |
| Poster Presentations | |
| 14:00-14:20 | Title: Longitudinal effects of direct observation of hand hygiene practices and monitoring of alcohol-based handrub consumption |
| Retsu Fujita, International University of Health and Welfare, Japan | |
| 14:20-14:40 | Title: Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses |
| Zhujun Ao, University of Manitoba, Canada | |
| 14:40-15:00 | Title:TBA |
| Yuqing Liu, Yangtze University, China | |
| 15:00-15:20 | Title: Role of some antimicrobial peptides during ZIKA virus infection in keratinocyte cell line |
| Victor Javier Cruz Holguin, Cinvestav, Mexico | |
| 15:20-15:40 | Title: Genomic Characterization of Circulating Human Respiratory Syncytial Viruses A and B in Kuwait using whole-genome Sequencing |
| Nada Madi, Kuwait University, Kuwait | |
| 15:40-16:00 | Speaker Slot available |
| Award & Closing Ceremony | |
| Day 2 Concludes | |
posters agenda
| Virtual Program | |
| Day -2 (June 25, 2024, Tuesday) | |
| Time Zone: Central European Time (CET) | |
| Virtual Presentation Through ZOOM | |
| 10:00-10:20 | Title: Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai |
| Yaoli Wang, Daping Hospital, Army Medical University, China | |
| 10:20-10:40 | Title: Bacterial co-infection raises in-hospital mortality of COVID-19 patients: a retrospective study |
| Shiying Li, The second affiliated hospital of Chongqing Medical University, China | |
| 10:40-11:00 | Title: An analysis of virus-host interaction: case study for HIV-infection |
| Olga Tarasova, Institute of Biomedical Chemistry, Russia | |
| 11:00-11:20 | Title: Dual role of follicular regulatory T cells in the control of B cell response to vaccination |
| Irina L Grigorova, Pirogov Russian National Research Medical University, Russia | |
| 11:20-11:40 | Title: Commentary on the impact of the COVID-19 passports in Lithuania |
| Rimas Jonas Jankunas, Lithuanian University of Health Sciences, Lithuania | |
| 11:40-12:00 | Title: Small molecules against arthropod-borne infectious diseases: A case study of acetylphloroglucinols from hops crops as potential therapeutics against Chikungunya |
| Tsvetelina Mandova, Gilson, France | |
| 12:00-12:20 | Title: Corruption is making people sick |
| Oliver Charles Campbell White, Rowan Health Associates, United Kingdom | |
| 12:20-12:40 | Speaker Slot available |
| 12:40-13:00 | Title: Thirteen Cases of Pulmonary Pneumocystis in HIV-Negative Patients |
| Abir Bouhamdi, Hassan II University Hospital, Morocco | |
| 13:00-13:20 | Title: Diagnostic Approach to Hypersensitivity Pneumonitis: A Report of Two Cases |
| Chaynez Rachid, chu mohammed VI , Morocco | |
| 13:20-13:40 | Title: ANTIMICROBIAL POTENTIAL OF CREAMS BASED ON Phyllanthus niruri and Myracrodruon urundeuva IN POST-OVARIOHYSTERECTOMY WOUNDS in Felis catus |
| Francisco Marlon Carneiro Feijo, UFERSA, Brazil Brazil | |
| 13:40-14:00 | Title: Distinct mechanisms regulate the exposure of Broadly Neutralizing Antibody Epitopes on HIV-1 particles |
| Chitra Upadhyay, Icahn School of Medicine at Mount Sinai, USA | |
| 14:00-14:20 | Title: Meta-analysis of direct endovascular thrombectomy vs bridging therapy in the management of acute ischemic stroke with large vessel occlusion |
| Luke world, University of Florida, USA | |
| 14:20-14:40 | Title: FusionNeoAntigen: a resource of fusion gene-specific neoantigens |
| Pora Kim, The University of Texas Health Science Center at Houston, USA | |
| 14:40-15:00 | Title: Causal frameworks for designing studies of immune correlates of risk for vaccine-preventable diseases: Start with the Target Trial Protocol, then follow the Roadmap for Causal Inference |
| Lauren E. Dang, National Institute of Allergy and Infectious Diseases, USA | |
| 15:00-15:20 | Title: Evaluation of the effect of ALFQA adjuvant on immunogenicity and efficacy of the V1-deleted DNA/ALVAC/gp120 anti-HIV vaccine candidate |
| Massimiliano Bissa, NCI/NIH, USA | |
| 15:20-15:40 | Title: Targeting Intracellular Neu1 for Coronavirus Infection Treatment |
| Guoyun Chen, UTHSC, USA | |
| 15:40-16:00 | Title: The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion |
| Ping Xie, Rutgers University, USA | |
| 16:00-16:20 | Title: Strength and weakness revealed during research and clinical response to the COVID-19 pandemic |
| Lee Shapiro, University of Colorado Anschutz Medical Campus, USA | |
| 16:20-16:40 | Title: Clinical Approach to Fatigue in Long COVID: Implementing Lessons Learned from Myalgic Encephalomyelitis Chronic Fatigue Syndrome |
| Alba Miranda Azola, Johns Hopkins University, USA | |
| 16:40-17:00 | Title: Pulmonary Surfactant Lipids: Novel compounds as antivirals |
| Mari Numata-Nakamura, National Jewish Health, USA | |
| 17:00-17:20 | Title: Bayesian Analyses for Adaptive Clinical Trial Designs: Application to Lecanemab Phase 2b Dose-finding Trial in Alzheimer Disease |
| Donald Arthur Berry, M.D. Anderson Cancer Center of the University of Texas, USA | |
| Day Concludes | |
| NOTE: This is Tentative program and subject to change | |
| For more information, Contact @ ryan_cooper@vaccine-congress | |